Variational AI will participate in the upcoming Boston Pharmaceutical & Bioscience Society (PBSS) event, “Artificial Intelligence and Machine Learning: Shaping the Future of Therapeutic Drug Discovery, Development, and Manufacturing,” taking place April 28, 2026, in Cambridge, MA. This full-day symposium brings together leaders from biotechnology, academia, and pharmaceutical companies to discuss how artificial intelligence and…

Learn More about Variational AI to Present at PBSS Event on AI and ML in Drug Discovery

Variational AI will participate in MaRS Impact Health, a flagship health innovation event hosted by MaRS Discovery District that brings together entrepreneurs, investors, scientists, clinicians, and policymakers working to advance the future of healthcare. Meet with Variational AI If you are attending MaRS Impact Health and would like to connect with Variational AI to learn…

Learn More about Variational AI to Participate in the MaRS Impact Health Summit

Variational AI will participate in the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), one of North America’s leading gatherings for healthcare investors and emerging life sciences companies. Meet with Variational AI Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will attend the conference to meet with investors and discuss the company’s approach…

Learn More about Variational AI to Participate in the Bloom Burton Healthcare Investor Conference

Variational AI will participate in ALL IN Talks West, an event bringing together researchers, industry leaders, builders, and decision-makers focused on the practical deployment of artificial intelligence systems in real-world environments. “From World-Class Research to Market Impact: Closing the Adoption Gap.” Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will speak on April…

Learn More about Variational AI to speak at ALL IN Talks West

Variational AI will participate in Drug Discovery Chemistry 2026, a premier conference for scientists focused on the discovery and optimization of small-molecule therapeutics. The event brings together medicinal, biophysical, and computational chemists from pharmaceutical companies, biotechnology organizations, and academic institutions to discuss new strategies and technologies for advancing drug discovery. Meet with Variational AI Brian…

Learn More about Variational AI at Drug Discovery Chemistry 2026

Variational AI is excited to participate in the inaugural AI Convergence: Small Molecule Discovery Summit in Boston, bringing together leaders at the intersection of AI/ML, computational chemistry, and medicinal chemistry. This is a great venue to compare notes on how generative approaches are being applied to real-world small-molecule design workflows (from hit expansion to multiparameter…

Learn More about Variational AI at AI Convergence: Small Molecule Discovery Summit 2026

Variational AI will be at Life Sciences BC’s 11th Annual Access to Innovation on February 25, 2026 in Vancouver. Connect with our team to discuss how generative AI is changing small-molecule discovery.

Learn More about Variational AI at LSBC’s 11th Annual Access to Innovation

We’re happy to share that Variational AI will be participating in the OBIO® Investment Summit in Toronto. Taking place February 3–5, 2026 at Arcadian Court & Loft (401 Bay Street, Simpson Tower, 8th Floor), the OBIO® Investment Summit is Canada’s premier health science investment event, bringing together global investors, strategic partners, and high-growth life sciences…

Learn More about Variational AI at OBIO Investment Summit 2026

Each January, the J.P. Morgan Healthcare Conference turns San Francisco into the global epicenter of biotech, pharma, and healthcare investing. It is widely regarded as the industry’s largest and most influential healthcare investment symposium, bringing together global industry leaders, emerging biotech companies, and investors to set the tone for the year ahead. Around the main…

Learn More about Variational AI at JPM Week and Biotech Showcase 2026

Join Rakovina Therapeutics and Variational AI for a 60-minute fireside chat on how deep biology and generative AI are coming together to tackle one of oncology’s toughest problems

Learn More about Webinar | From Handshake to Breakthrough: How Rakovina & Variational AI are Cracking the Code on CNS-Penetrant Cancer Therapies

We are pleased to share that Variational will be attending BIO-Europe 2025, Europe’s leading biopharma partnering event. We’ll be there to network with industry leaders, explore strategic partners, and showcase what we’re working on. If you plan on attending, let’s connect!

Learn More about Variational at BIO-Europe 2025

Variational is excited to announce that we will be participating in BioJapan 2025, Asia’s premier bio-industry partnering event. We’ll be on site to meet partners, explore collaboration opportunities, and share our latest innovations in biotechnology & drug discovery. Come visit us at our booth to connect in person!

Learn More about Variational Will Be at BioJapan 2025